Home
TSHA
TSHA News

Latest Taysha Gene Therapies Inc. (TSHA) News on August 17, 2025

Jefferies Maintains a Buy on Taysha Gene Therapies (TSHA) With an $8 PT

Insider Monkey

2 months ago

Jefferies Maintains a Buy on Taysha Gene Therapies (TSHA) With an $8 PT

Craig-Hallum bullish on Neurogene, initiates with a Buy

TipRanks

2 months ago

Craig-Hallum bullish on Neurogene, initiates with a Buy

MT Newswires

2 months ago

Cantor Fitzgerald Adjusts Price Target on Taysha Gene Therapies to $13 From $7, Maintains Overweight Rating

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

2 months ago

Taysha Gene Therapies Insider Bought Shares Worth $2,062,500, According to a Recent SEC Filing

Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program

GlobeNewswire

2 months ago

Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program

MT Newswires

2 months ago

Needham Adjusts Taysha Gene Therapies Price Target to $8 From $6, Maintains Buy Rating

MT Newswires

3 months ago

Chardan Raises Price Target on Taysha Gene Therapies to $9 From $7, Keeps Buy Rating

MT Newswires

3 months ago

Taysha Gene Therapies Prices Share, Pre-Funded Warrant Offering

Taysha Gene Therapies, Inc. (TSHA)’s TSHA-102 Shows Promising Results in Rett Syndrome Patients Aged 6+

Insider Monkey

3 months ago

Taysha Gene Therapies, Inc. (TSHA)’s TSHA-102 Shows Promising Results in Rett Syndrome Patients Aged 6+

Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

3 months ago

Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

MT Newswires

3 months ago

Taysha Gene Therapies Commences Offering of Common Stock, Warrants

Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

3 months ago

Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Taysha Gene Therapies Announces Pivotal Part B Trial Design Details for TSHA-102 in Rett Syndrome Enabled by IRSF Natural History Data and Positive Clinical Data from Part A of the REVEAL Adult/Adolescent and Pediatric Trials Evaluating TSHA-102

GlobeNewswire

3 months ago

Taysha Gene Therapies Announces Pivotal Part B Trial Design Details for TSHA-102 in Rett Syndrome Enabled by IRSF Natural History Data and Positive Clinical Data from Part A of the REVEAL Adult/Adolescent and Pediatric Trials Evaluating TSHA-102

Thomson Reuters StreetEvents

3 months ago

Q1 2025 Taysha Gene Therapies Inc Earnings Call

Taysha Gene Therapies Inc (TSHA) Q1 2025 Earnings Call Highlights: Promising Clinical Progress ...

GuruFocus.com

3 months ago

Taysha Gene Therapies Inc (TSHA) Q1 2025 Earnings Call Highlights: Promising Clinical Progress ...

Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Tops Revenue Estimates

Zacks

3 months ago

Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Tops Revenue Estimates

Taysha Gene Therapies Reports First Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire

3 months ago

Taysha Gene Therapies Reports First Quarter 2025 Financial Results and Provides Corporate Update

Taysha Gene Therapies Inc (TSHA) Q1 2025 Earnings Report Preview: What To Expect

GuruFocus.com

3 months ago

Taysha Gene Therapies Inc (TSHA) Q1 2025 Earnings Report Preview: What To Expect

Taysha Gene Therapies to Release First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15

GlobeNewswire

3 months ago

Taysha Gene Therapies to Release First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15

Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know

Zacks

3 months ago

Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know

Assembly Biosciences (ASMB) Soars 24.0%: Is Further Upside Left in the Stock?

Zacks

3 months ago

Assembly Biosciences (ASMB) Soars 24.0%: Is Further Upside Left in the Stock?

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

4 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Discover Fractyl Health And 2 More Promising Penny Stocks

Simply Wall St.

4 months ago

Discover Fractyl Health And 2 More Promising Penny Stocks

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

4 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks

5 months ago

Biotech stocks slide as Marks resignation seen being negative for sector

Is Taysha Gene Therapies (TSHA) the Best Short Squeeze Stock to Buy According to Analysts?

Insider Monkey

5 months ago

Is Taysha Gene Therapies (TSHA) the Best Short Squeeze Stock to Buy According to Analysts?

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

5 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Nano Dimension And 2 Other Penny Stocks To Watch Now

Simply Wall St.

5 months ago

Nano Dimension And 2 Other Penny Stocks To Watch Now

Taysha Gene Therapies Full Year 2024 Earnings: Beats Expectations

Simply Wall St.

6 months ago

Taysha Gene Therapies Full Year 2024 Earnings: Beats Expectations

Thomson Reuters StreetEvents

6 months ago

Q4 2024 Taysha Gene Therapies Inc Earnings Call

Taysha Gene Therapies, Inc. (TSHA) Reports Q4 Loss, Tops Revenue Estimates

Zacks

6 months ago

Taysha Gene Therapies, Inc. (TSHA) Reports Q4 Loss, Tops Revenue Estimates

Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire

6 months ago

Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Provides Corporate Update

Taysha Gene Therapies Inc (TSHA) Q4 2024: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

6 months ago

Taysha Gene Therapies Inc (TSHA) Q4 2024: Everything You Need To Know Ahead Of Earnings

Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26

GlobeNewswire

6 months ago

Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Scienjoy Holding Leads Our 3 US Penny Stocks To Consider

Simply Wall St.

6 months ago

Scienjoy Holding Leads Our 3 US Penny Stocks To Consider

Acelyrin Leads The Charge With 2 Other US Penny Stocks

Simply Wall St.

7 months ago

Acelyrin Leads The Charge With 2 Other US Penny Stocks

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

7 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

8 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

9 months ago

Taysha Gene Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Thomson Reuters StreetEvents

9 months ago

Q3 2024 Taysha Gene Therapies Inc Earnings Call

Taysha Gene Therapies Inc (TSHA) Q3 2024 Earnings Call Highlights: Clinical Progress and ...

GuruFocus.com

9 months ago

Taysha Gene Therapies Inc (TSHA) Q3 2024 Earnings Call Highlights: Clinical Progress and ...

Taysha Gene Therapies, Inc. (TSHA) Reports Q3 Loss, Lags Revenue Estimates

Zacks

9 months ago

Taysha Gene Therapies, Inc. (TSHA) Reports Q3 Loss, Lags Revenue Estimates

Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

9 months ago

Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update

US Penny Stocks To Watch In November 2024

Simply Wall St.

9 months ago

US Penny Stocks To Watch In November 2024

Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13

GlobeNewswire

9 months ago

Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

10 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress

GlobeNewswire

10 months ago

Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress

Is Taysha Gene Therapies, Inc. (TSHA) the Most Promising Biotech Stock According to Hedge Funds?

Insider Monkey

10 months ago

Is Taysha Gene Therapies, Inc. (TSHA) the Most Promising Biotech Stock According to Hedge Funds?

Taysha Gene Therapies (TSHA) Upgraded to Strong Buy: Here's Why

Zacks

10 months ago

Taysha Gene Therapies (TSHA) Upgraded to Strong Buy: Here's Why

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

10 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Is Taysha Gene Therapies, Inc. (TSHA) the Best NASDAQ Stock Under $5?

Insider Monkey

10 months ago

Is Taysha Gene Therapies, Inc. (TSHA) the Best NASDAQ Stock Under $5?

Taysha Gene Therapies Announces Oral Presentation on TSHA-102 in Rett Syndrome at Upcoming 9th World Rett Syndrome Congress

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Oral Presentation on TSHA-102 in Rett Syndrome at Upcoming 9th World Rett Syndrome Congress

Bausch (BHC) Surges 11.7%: Is This an Indication of Further Gains?

Zacks

a year ago

Bausch (BHC) Surges 11.7%: Is This an Indication of Further Gains?

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a year ago

Taysha Gene Therapies Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Taysha Gene Therapies, Inc. (TSHA) Reports Q2 Loss, Lags Revenue Estimates

Zacks

a year ago

Taysha Gene Therapies, Inc. (TSHA) Reports Q2 Loss, Lags Revenue Estimates

Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) has caught the attention of institutional investors who hold a sizeable 46% stake

Simply Wall St.

a year ago

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) has caught the attention of institutional investors who hold a sizeable 46% stake

Taysha Gene Therapies to Release Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 12

GlobeNewswire

a year ago

Taysha Gene Therapies to Release Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 12

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 07/02/2024

Insider Buyers At Taysha Gene Therapies Sitting On US$24m Profit

Simply Wall St.

a year ago

Insider Buyers At Taysha Gene Therapies Sitting On US$24m Profit

MT Newswires

a year ago

Taysha Gene Therapies Insider Bought Shares Worth $2,999,999, According to a Recent SEC Filing

MT Newswires

a year ago

BMO Initiates Taysha Gene Therapies at Outperform With $5 Price Target

MT Newswires

a year ago

Taysha Gene Therapies Prices $75 Million Offering of Shares, Pre-Funded Warrants; Shares Fall

Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

MT Newswires

a year ago

Top Premarket Decliners

MT Newswires

a year ago

Taysha Gene Therapies Starts $75 Million Common Stock Offering

Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome

Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short

BioPharma Dive

a year ago

Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short

Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Hosted Webcast and at 2024 IRSF Rett Syndrome Scientific Meeting

GlobeNewswire

a year ago

Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Hosted Webcast and at 2024 IRSF Rett Syndrome Scientific Meeting

Trip.com Reveals 2024 Trip.Best Global and Asia 100 Rankings

CNW Group

a year ago

Trip.com Reveals 2024 Trip.Best Global and Asia 100 Rankings

The Company Behind Mounjaro and Zepbound Is Sponsoring Caitlin Clark. Should You Buy the Stock?

Motley Fool

a year ago

The Company Behind Mounjaro and Zepbound Is Sponsoring Caitlin Clark. Should You Buy the Stock?

3 Capital Markets Stocks to Buy Hand Over Fist in June

Motley Fool

a year ago

3 Capital Markets Stocks to Buy Hand Over Fist in June

3 Types of Homes To Buy During Summer 2024 To Get Rich

GOBankingRates

a year ago

3 Types of Homes To Buy During Summer 2024 To Get Rich

4 Ways the Upper Class Handles Inflation That the Middle Class Could Learn From

GOBankingRates

a year ago

4 Ways the Upper Class Handles Inflation That the Middle Class Could Learn From

Gaming laptops are being left behind

Digital Trends

a year ago

Gaming laptops are being left behind

I’m a Financial Advisor: Here Are the 6 Worst Secrets You Can Keep from Me

GOBankingRates

a year ago

I’m a Financial Advisor: Here Are the 6 Worst Secrets You Can Keep from Me

What a Comfortable Retirement Will Cost You in 61 of the Largest US Cities

GOBankingRates

a year ago

What a Comfortable Retirement Will Cost You in 61 of the Largest US Cities

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Is Taysha Gene Therapies, Inc. (NASDAQ:TSHA) the Best Gene Therapy Company?

Insider Monkey

a year ago

Is Taysha Gene Therapies, Inc. (NASDAQ:TSHA) the Best Gene Therapy Company?

GuruFocus.com

a year ago

Taysha Gene Therapies Inc (TSHA) Q1 2024 Earnings Call Transcript Highlights: Navigating ...

Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Lags Revenue Estimates

Zacks

a year ago

Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Lags Revenue Estimates

MT Newswires

a year ago

Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours

Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update

Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14

GlobeNewswire

a year ago

Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know

Zacks

a year ago

Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know

Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome

These 2 ‘Strong Buy’ Penny Stocks Could Rally to $9, Says Piper Sandler

TipRanks

a year ago

These 2 ‘Strong Buy’ Penny Stocks Could Rally to $9, Says Piper Sandler

Analysts' Revenue Estimates For Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Are Surging Higher

Simply Wall St.

a year ago

Analysts' Revenue Estimates For Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Are Surging Higher

Certain Biotech Investors Get an Early Look at Results. Is That Fair?

The Wall Street Journal

a year ago

Certain Biotech Investors Get an Early Look at Results. Is That Fair?

Certain Biotech Investors Get an Early Look at Results. Is That Fair?

The Wall Street Journal

a year ago

Certain Biotech Investors Get an Early Look at Results. Is That Fair?

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

News Flash: Analysts Just Made A Notable Upgrade To Their Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Forecasts

Simply Wall St.

a year ago

News Flash: Analysts Just Made A Notable Upgrade To Their Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Forecasts

Taysha Gene Therapies Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

a year ago

Taysha Gene Therapies Full Year 2023 Earnings: Beats Expectations

Share on Social Networks: